At a glance
- Originator Pfizer
- Class Antiemetics
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 03 Jul 2000 Profile reviewed but no significant changes made
- 03 Feb 1997 No-Development-Reported for Emesis in USA (Unknown route)